December 23rd, 2011
MIRADOR BIOMEDICAL Receives 510(k) Clearance for Expanded Compass™ Platform, Launches Thoracentesis and Compartment Pressure Monitoring Products
July 28th, 2011
Mirador Recieves CE Mark for Compass Platform
April 12th, 2011
Mirador Closes $1.5M Series B Round
February 14th, 2011
Mirador Biomedical Expands Commercialization And Appoints Steve Gappa Vice President Of Sales
October 15th, 2010
Mirador Biomedial Announces 510(k) Clearance of the Compass™ Vascular Access and Compass™ Lumbar Puncture Devices
August 11th, 2010
Commercialization Grant Awarded to Test Mirador Biomedical’s Compass Lumbar Puncture Device
July 8th, 2010
Mirador Biomedical Submits 510(k) Application to FDA
April 16th, 2010
John Harris appointed to Board of Directors
March 19th, 2010
Mirador Biomedical Closes Series A Round
Mirador Biomedical closes $1.1 million Series A Round of Funding (PDF)
October 8th, 2009
Tom Clement joins Board of Directors
Pathway Medical Co-Founder and Board Chairman, Tom Clement, joins Mirador Biomedical Board of Directors (PDF)

